Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: Technical recommendations

Journal of Vascular and Interventional Radiology

Volumn 25, Issue 3, 2014, Pages 365-369

  Lencioni, Riccardo ^a   Aliberti, Camillo ^b   De Baere, Thierry ^c   Garcia Monaco, Ricardo ^d   Narayanan, Govindarajan ^e   O'Grady, Elizabeth ^h   Rilling, William S ^f   Walker, Duncan ⁱ   Martin, Robert C G ^g  

^a UNIVERSITY OF PISA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g University of Louisville School of Medicine   (United States)

^h UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

ⁱ WESLEY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DC BEAD; IRINOTECAN; IRINOTECAN LOADED DRUG ELUTING BEAD; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL EXAMINATION; CLINICAL PROTOCOL; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; HEPATIC ARTERY; HUMAN; IMAGING SYSTEM; LABORATORY TEST; PATIENT SELECTION; PRIORITY JOURNAL; STANDARDIZATION;

CAMPTOTHECIN; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY; DRUG-ELUTING STENTS; HUMANS; INJECTIONS, INTRA-ARTERIAL; INTERNATIONALITY; LIVER NEOPLASMS; PRACTICE GUIDELINES AS TOPIC;

EID: 84896806046     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.11.027     Document Type: Article

References (21)

1. International Agency for Research on Cancer. World Health Organization. GLOBOCAN 2008: Estimated cancer incidence, mortality, prevalence and disability-adjusted life years worldwide in 2008. Available at http://globocan.iarc.fr/. Accessed March 1, 2013.
2. R.E. Brown, M.R. Bower, and R.C. Martin Hepatic resection for colorectal liver metastases Surg Clin North Am 90 2010 839 852
3. R.B. Adams, T.A. Aloia, E. Loyer, T.M. Pawlik, B. Taouli, and J.N. Vauthey Selection for hepatic resection of colorectal liver metastases: expert consensus statement HPB (Oxford) 15 2013 91 103
4. C.R. Hill, R.B. Chagpar, and G.G. Callender et al. Recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival Ann Surg Oncol 19 2012 139 144
5. R.C. Martin, R. Salem, R. Adam, and E. Dixon Locoregional surgical and interventional therapies for advanced colorectal liver metastasis: expert consensus statement HPB (Oxford) 15 2013 131 133
6. A.H. Mahnken, P.L. Pereira, and T. de Baere Interventional oncologic approaches to liver metastases Radiology 266 2013 407 430
7. A.L. Lewis, R.R. Holden, and S.T. Chung et al. Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model J Mater Sci Mater Med 24 2013 115 127
8. P.P. Rao, F. Pascale, and A. Seck et al. Irinotecan loaded in eluting beads: preclinical assessment in a rabbit VX2 liver tumor model Cardiovasc Intervent Radiol 35 2012 1448 1459
9. C. Aliberti, G. Fiorentini, and P.C. Muzzio et al. Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead, drug-eluting bead loaded with irinotecan: results of a phase II clinical study Anticancer Res 31 2011 4581 4587
10. R.C. Martin, J. Joshi, and K. Robbins et al. Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study Ann Surg Oncol 18 2011 192 198
11. R.C. Martin, C.R. Scoggins, and D. Tomalty et al. Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial J Gastrointest Surg 16 2012 1531 1538
12. G. Fiorentini, C. Aliberti, and M. Tilli et al. Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study Anticancer Res 32 2012 1387 1395
13. R.C. Martin, J. Howard, and D. Tomalty et al. Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry Cardiovasc Intervent Radiol 33 2010 960 966
14. A.J. Richardson, J.M. Laurence, and V.W. Lam Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review J Vasc Interv Radiol 24 2013 1209 1217
15. O. Jordan, A. Denys, T. De Baere, N. Boulens, and E. Doelker Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan J Vasc Interv Radiol 21 2010 1084 1090
16. M. Bower, T. Metzger, and K. Robbins et al. Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study HPB (Oxford) 12 2010 31 36
17. R.E. Brown, M.R. Bower, and T.L. Metzger et al. Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe? HPB (Oxford) 13 2011 91 95
18. A. Marques, R. Garcia, F. Gomez, and G. Fiorentini Ultrasound-guided paravertebral block for management of abdominal pain after transarterial embolization using drug-eluting beads loaded with irinotecan J Vasc Interv Radiol 24 2013 1416 1417
19. R.P. Jones, R. Jackson, and D.F.J. Dunne et al. Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases Br J Surg 99 2012 477 486
20. R.P. Jones, D. Dunne, and P. Sutton et al. Segmental and lobar administration of drug-eluting beads delivering irinotecan leads to tumour destruction: a case-control series HPB (Oxford) 15 2013 71 77
21. R.P. Jones, S. Stättner, and D.F. Dunne et al. Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI) for colorectal liver metastases does not predict tumour destruction or long-term outcome Eur J Surg Oncol 39 2013 1122 1128